Blackstone Inc
RPTX

Blackstone Inc’s Repare Therapeutics RPTX Stock Holding History

Blackstone Inc’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25,957
Closed -$45.7K – 296
2025
Q3 		$45.7K Hold
25,957
– – ﹤0.01% 244
2025
Q2 		$36.1K Hold
25,957
– – ﹤0.01% 166
2025
Q1 		$25.7K Hold
25,957
– – ﹤0.01% 171
2024
Q4 		$34K Hold
25,957
– – ﹤0.01% 162
2024
Q3 		$89.3K Hold
25,957
– – ﹤0.01% 158
2024
Q2 		$85.7K Hold
25,957
– – ﹤0.01% 172
2024
Q1 		$122K Hold
25,957
– – ﹤0.01% 171
2023
Q4 		$189K Hold
25,957
– – ﹤0.01% 153
2023
Q3 		$314K Buy
25,957
+3,362
+15% +$34.7K ﹤0.01% 142
2023
Q2 		$239K Hold
22,595
– – ﹤0.01% 144
2023
Q1 		$222K Hold
22,595
– – ﹤0.01% 151
2022
Q4 		$332K Buy
22,595
+3,427
+18% +$51.3K ﹤0.01% 144
2022
Q3 		$233K Sell
19,168
-2
-0% -$26 ﹤0.01% 188
2022
Q2 		$268K Buy
19,170
+7,333
+62% +$86.4K ﹤0.01% 209
2022
Q1 		$169K Hold
11,837
– – ﹤0.01% 222
2021
Q4 		$250K Hold
11,837
– – ﹤0.01% 378
2021
Q3 		$311K Buy
+11,837
New +$382K ﹤0.01% 428
2020
Q3 		– Sell
-30,000
Closed -$931K – 198
2020
Q2 		$931K Buy
+30,000
New +$963K ﹤0.01% 136

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Blackstone Inc's RPTX Position: Q4 2025 in Review

Blackstone Inc sold out of Repare Therapeutics (RPTX) in Q4 2025, closing a stake of 25,957 shares — an estimated $45.7K sold.

Blackstone Inc first reported a position in RPTX in Q2 2020 and held it in 18 quarters. The position peaked at $931K in Q2 2020. 46 funds tracked by Wall St. Rank hold RPTX as of Q4 2025.

  • Blackstone Inc reported no remaining Repare Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Blackstone Inc sold 25,957 Repare Therapeutics shares in Q4 2025, an estimated $45.7K.
  • Blackstone Inc first reported a position in Repare Therapeutics in Q2 2020 and held it in 18 quarters.
  • Blackstone Inc's Repare Therapeutics position peaked at $931K in Q2 2020.
  • 46 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2025.

Based on Blackstone Inc's 13F filing for Q4 2025, filed 17 Feb 2026.